147 related articles for article (PubMed ID: 8496613)
1. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin.
Campbell C; Quinn AG; Ro YS; Angus B; Rees JL
J Invest Dermatol; 1993 Jun; 100(6):746-8. PubMed ID: 8496613
[TBL] [Abstract][Full Text] [Related]
2. The relation between p53 mutation and p53 immunostaining in non-melanoma skin cancer.
Campbell C; Quinn AG; Angus B; Rees JL
Br J Dermatol; 1993 Sep; 129(3):235-41. PubMed ID: 8286219
[TBL] [Abstract][Full Text] [Related]
3. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutations in human epithelial skin cancers.
Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
[TBL] [Abstract][Full Text] [Related]
5. [The tumor suppressor gene p53 and its significance for dermatology].
Lübbe J; Kleihues P; Burg G
Hautarzt; 1994 Nov; 45(11):741-5. PubMed ID: 7822196
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light.
Takata M; Rehman I; Rees JL
Int J Cancer; 1997 May; 71(3):370-2. PubMed ID: 9139870
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin.
Saridaki Z; Liloglou T; Zafiropoulos A; Koumantaki E; Zoras O; Spandidos DA
Br J Dermatol; 2003 Apr; 148(4):638-48. PubMed ID: 12752119
[TBL] [Abstract][Full Text] [Related]
9. Subclonal Evolution of Cancer-Related Gene Mutations in p53 Immunopositive Patches in Human Skin.
Albibas AA; Rose-Zerilli MJJ; Lai C; Pengelly RJ; Lockett GA; Theaker J; Ennis S; Holloway JW; Healy E
J Invest Dermatol; 2018 Jan; 138(1):189-198. PubMed ID: 28844940
[TBL] [Abstract][Full Text] [Related]
10. p53 protein expression in benign and malignant skin tumours.
Ro YS; Cooper PN; Lee JA; Quinn AG; Harrison D; Lane D; Horne CH; Rees JL; Angus B
Br J Dermatol; 1993 Mar; 128(3):237-41. PubMed ID: 8471506
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis.
Kubo Y; Urano Y; Yoshimoto K; Iwahana H; Fukuhara K; Arase S; Itakura M
J Invest Dermatol; 1994 Apr; 102(4):440-4. PubMed ID: 8151121
[TBL] [Abstract][Full Text] [Related]
12. Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein.
Castrén K; Vähäkangas K; Heikkinen E; Ranki A
Int J Cancer; 1998 Aug; 77(5):674-8. PubMed ID: 9688297
[TBL] [Abstract][Full Text] [Related]
13. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
[TBL] [Abstract][Full Text] [Related]
14. Significance of mitotic cells or clumping cells in p53 immunopositivity of Bowen's disease.
Ura H; Nashiro K; Kikuchi K; Imakado S; Matsukawa A; Furue M
Dermatology; 1997; 194(1):87-8. PubMed ID: 9031804
[No Abstract] [Full Text] [Related]
15. Aneuploidy in actinic keratosis and Bowen's disease--increased risk for invasive squamous cell carcinoma?
Biesterfeld S; Pennings K; Grussendorf-Conen EI; Böcking A
Br J Dermatol; 1995 Oct; 133(4):557-60. PubMed ID: 7577583
[TBL] [Abstract][Full Text] [Related]
16. Aneuploidy in Bowen's disease.
Newton JA; Camplejohn RS; McGibbon DH
Br J Dermatol; 1986 Jun; 114(6):691-4. PubMed ID: 3718863
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer.
McGregor JM; Yu CC; Dublin EA; Levison DA; MacDonald DM
Br J Dermatol; 1992 Nov; 127(5):463-9. PubMed ID: 1467284
[TBL] [Abstract][Full Text] [Related]
18. Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer.
Campbell C; Quinn AG; Rees JL
Br J Dermatol; 1993 Feb; 128(2):111-4. PubMed ID: 8096149
[TBL] [Abstract][Full Text] [Related]
19. A clonal t(9;12)(q32;q21) in cultured fibroblasts from a case of Bowen's disease.
Scappaticci S; Lambiase S; Fraccaro M; Orecchia G
Cancer Genet Cytogenet; 1989 Dec; 43(2):249-50. PubMed ID: 2598169
[No Abstract] [Full Text] [Related]
20. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours.
Hida Y; Kubo Y; Arase S
Br J Dermatol; 2009 Jun; 160(6):1258-63. PubMed ID: 19298285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
